We all want to live longer and healthier lives, so it’s no surprise that healthcare technology is a major area of research and innovation. Medtech and biotech are key investment themes in the Telescope Investing model portfolio, and in our own personal portfolios.

This week we had the pleasure of connecting with healthtech expert investor Richard Chu. Richard shares his thoughts on the healthtech sector, his key investments in this area including GoodRx, Doximity, and OptimizeRx, and also how he saw the writing on the wall for Teladoc Health and exited early, avoiding the share price slump that has hurt our own returns this year!